PROTALIX BIOTHERAPEUTICS INC's ticker is and the CUSIP is 74365AAJ0. A total of 4 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $145,000 | -99.0% | 12,500,000 | 0.0% | 0.01% | -99.1% |
| Q2 2023 | $14,952,188 | +8306671.1% | 12,500,000 | -16.7% | 0.66% | +9314.3% |
| Q1 2023 | $180 | -98.8% | 15,000,000 | 0.0% | 0.01% | -98.4% |
| Q4 2022 | $15,525 | -100.0% | 15,000,000 | 0.0% | 0.43% | -98.0% |
| Q3 2022 | $1,501,410,000 | +9760.8% | 15,000,000 | 0.0% | 21.08% | +5975.8% |
| Q2 2022 | $15,226,000 | -12.5% | 15,000,000 | 0.0% | 0.35% | -14.3% |
| Q1 2022 | $17,400,000 | +23.5% | 15,000,000 | 0.0% | 0.40% | +31.5% |
| Q4 2021 | $14,086,000 | – | 15,000,000 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 15,000,000 | $1,501,410,000 | 21.08% |
| WHITEBOX ADVISORS LLC | 5,000,000 | $4,904,000 | 0.14% |
| UBS OCONNOR LLC | 4,000,000 | $4,200,000,000 | 0.08% |
| CITIGROUP INC | 2,500,000 | $2,452,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |